#1. Legislative History
N. 1 Art. 120 FC was created during the total revision of the Federal Constitution in 1999 and replaced the former Art. 24novies old FC (inserted in 1992). The constitutional provision responded to the rapid developments in genetic technology and the social need for legal guidelines for these new technologies (BBl 1997 I 256). The provision was later supplemented by transitional provision Art. 197 no. 7 FC, which provided for a five-year moratorium on the agricultural use of genetically modified organisms.
N. 2 With Art. 120 FC, the constitutional legislator pursued three central goals: protection against misuse of genetic technology, preservation of the dignity of creatures, and protection of genetic diversity. The concept of «dignity of creatures» represented a novelty in constitutional law and triggered intense debates about its normative content (BBl 1997 I 256 f.).
#2. Systematic Classification
N. 3 Art. 120 FC is found in Section 8 «Housing, Work, Social Security and Health» and stands in close systematic connection with Art. 119 FC (reproductive medicine and genetic technology in the human field). The division of genetic technology regulation into human and non-human fields reflects the different ethical and legal standards in these areas.
N. 4 The norm has manifold cross-references: → Art. 73 FC (sustainability), → Art. 74 FC (environmental protection), → Art. 78 FC (nature and heritage protection), → Art. 80 FC (animal protection) as well as → Art. 104 FC (agriculture). These systematic references underscore the comprehensive protection claim of the constitution in the field of biotechnology.
#3. Elements of the Offence / Norm Content
N. 5 Art. 120 para. 1 FC establishes a general protection requirement against «misuse of genetic technology». The concept of misuse presupposes permissible use and thus implies that genetic technology is not prohibited per se, but only its abusive application.
N. 6 Art. 120 para. 2 sentence 1 FC establishes comprehensive federal competence for issuing regulations on the handling of germinal and genetic material. This competence encompasses all phases from closed systems through release trials to placing on the market.
N. 7 The central and most controversial concept is the «dignity of creatures» in Art. 120 para. 2 sentence 2 FC. The prevailing doctrine understands this to include only non-human living beings (Schmithüsen/Zachariae, Aspekte-Schaerer, 121 ff.), while a minority opinion also includes humans (Errass, Gentechnologie, 61 ff. and ZSR 2002 I 333 f.). The Federal Supreme Court clarified in BGE 135 II 405 E. 4.3 that the dignity of creatures exists independently of genetic technology and must also be respected outside this field.
N. 8 The «safety of humans, animals and the environment» forms another protected interest. It is controversial whether this also includes property protection: Errass (Gentechnologie, 53 f.; SG Komm. BV-Schweizer/Errass, Art. 120 N. 12) affirms this, while Epiney et al. (Gentechnikfreie Gebiete, Rz. 106 i.f., 132 ff.) deny it.
N. 9 The protection of «genetic diversity» aims at preserving biodiversity and stands in close connection with → Art. 78 FC (nature and heritage protection).
#4. Legal Consequences
N. 10 Art. 120 FC is primarily a competence norm that obligates the Confederation to issue protective regulations. Implementation occurred mainly through the Gene Technology Act (GTA), the Environmental Protection Act (particularly Art. 29a-h EPA) and the Agriculture Act (Art. 27a AgricA).
N. 11 The dignity of creatures has direct effect in the balancing of interests in concrete applications. The Federal Supreme Court held in BGE 135 II 384 that in animal experiments with primates, the dignity of creatures must be considered as a balancing factor.
N. 12 Art. 120 FC does not establish subjective rights for individuals, but shapes the interpretation and application of ordinary law in the sense of constitutionally conforming interpretation.
#5. Points of Controversy
N. 13 The concept of «creature» is the subject of a fundamental controversy: While the prevailing doctrine (Schmithüsen/Zachariae, Aspekte-Schaerer, 121 ff.) sees only non-human living beings as covered, Errass (Gentechnologie, 61 ff. and ZSR 2002 I 333 f.) advocates for the inclusion of humans. This question has direct implications for the scope of application of the norm.
N. 14 Also controversial is the scope of protection of «human safety»: Errass (Gentechnologie, 53 f.; SG Komm. BV-Schweizer/Errass, Art. 120 N. 12) and the St. Gallen commentary also see property protection as covered, while Epiney et al. (Gentechnikfreie Gebiete, Rz. 106 i.f., 132 ff.) reject this with regard to the specific property guarantee in → Art. 26 FC.
N. 15 The concrete scope of the dignity of creatures remains controversial. While the Federal Supreme Court advocates a pragmatic balancing solution (BGE 135 II 405), parts of the doctrine demand absolute limits to instrumentalization (ECNH, Die Würde der Kreatur bei Pflanzen, Bern 2008).
#6. Practice Guidelines
N. 16 For the authorization of release trials, a comprehensive risk assessment including all protected interests mentioned in Art. 120 FC is required. The authorities must demonstrate that they have included the dignity of creatures in their balancing (BGE 129 II 286).
N. 17 For the practice of cantonal animal experimentation committees, BGE 135 II 384 has set binding standards: The closer an animal stands to humans, the more significantly its interests must be considered in the balancing.
N. 18 The extended moratorium for GMOs in agriculture (Art. 37a GTA) limits the practical significance of Art. 120 FC in this area. Research in closed systems remains permissible, provided safety precautions are observed.
N. 19 The recent case law on fundamental rights for primates (BGE 147 I 183) shows that the dignity of creatures also has effect outside genetic technology and cantonal developments in this area are not excluded.